Dasiglucagon, a next‐generation ready‐to‐use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: results of a phase 3, randomized controlled trial
2019 ◽
Vol 21
(11)
◽
pp. 627-634
◽
2014 ◽
Vol 54
(2)
◽
pp. S41
◽
2006 ◽
Vol 32
(2)
◽
pp. 159-165
◽
2016 ◽
Vol 4
(1)
◽
pp. e000165
◽